AlphaMadera's AlphaVal page computes Co-Diagnostics, Inc.'s fair value using a multi-method blend (DCF, comparable-multiples, and Graham-style intrinsic value), then compares it to the current market price to flag CODX as undervalued, fairly valued, or overvalued.

What is Co-Diagnostics, Inc.'s fair value?

Fair value for CODX is a model output combining discounted cash flow projections, peer-group multiples, and a Graham number floor. The live AlphaVal page shows the blended fair value alongside each method's individual estimate.

How does AlphaMadera value CODX?

AlphaVal uses three primary techniques: a five-year discounted-cash-flow projection with terminal multiple, peer-group multiple analysis (P/E, EV/EBITDA, P/S), and Graham's defensive-investor intrinsic-value formula. Inputs come from CODX's most recent reported fundamentals.

CODX - Co-Diagnostics, Inc.

Price: -- -- | CONSENSUS: Hold DETAILS | PRICE TARGET: $180.00 DETAILS

AlphaVal

Deterministic, archetype-aware fair value

AlphaVal Unavailable

AlphaVal: CODX intrinsic value ($257) is 22x the stock price ($11.46). Likely stale financials (post-split price with pre-split EPS), ADR currency mismatch, or bad data.